Celgene (JOBS) 3rd-Quarter Profit Rises on Cancer Drug Sales

Bookmark and Share

Reuters -- Celgene Corp said on Thursday that its third-quarter earnings rose on higher sales of its blood cancer drugs.

MORE ON THIS TOPIC